Dr. Marc Schwartz, MD
Claim this profileUniversity of Colorado Hospital
Studies Ulcerative Colitis
Studies Acute Myeloid Leukemia
11 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Marc Schwartz, MD is currently running
Obefazimod
for Crohn's Disease
This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared to placebo as induction and maintenance therapy in subjects with moderately to severely active CD after inadequate response (no response, loss of response, or intolerance) to conventional therapies and/or advanced therapies. The primary objective for the 48-Week Extension Phase is to evaluate the safety and tolerability of obefazimod compared with placebo in subjects who are enrolled in the Extension Phase.
Recruiting0 awards Phase 24 criteria
CAR T Cell Therapy
for Acute Lymphoblastic Leukemia
This trial tests a new treatment using modified immune cells to target and destroy remaining cancer cells in adults with B-ALL who are in remission but still have some cancer left. The goal is to see if this approach is safe and effective. Modified immune cells have shown remarkable success in helping patients with recurring B-ALL achieve remission again.
Recruiting1 award Phase 1
More about Marc Schwartz, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Marc Schwartz, MD has experience with
- ABX464
- Placebo
- UCD19 CAR T
- Gleolan
- Prospective Determination Of The Clinical Utility Of Measurable Residual Disease (MRD) Testing
- Venetoclax
Breakdown of trials Marc Schwartz, MD has run
Ulcerative Colitis
Acute Myeloid Leukemia
Crohn's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Schwartz, MD specialize in?
Marc Schwartz, MD focuses on Ulcerative Colitis and Acute Myeloid Leukemia. In particular, much of their work with Ulcerative Colitis has involved treating patients, or patients who are undergoing treatment.
Is Marc Schwartz, MD currently recruiting for clinical trials?
Yes, Marc Schwartz, MD is currently recruiting for 4 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Marc Schwartz, MD has studied deeply?
Yes, Marc Schwartz, MD has studied treatments such as ABX464, Placebo, UCD19 CAR T.
What is the best way to schedule an appointment with Marc Schwartz, MD?
Apply for one of the trials that Marc Schwartz, MD is conducting.
What is the office address of Marc Schwartz, MD?
The office of Marc Schwartz, MD is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.